Jane Street’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-159,000
| Closed | -$15.6M | – | 10703 |
|
|
2025
Q2 | $15.6M | Buy |
159,000
+135,500
| +577% | +$12.8M | ﹤0.01% | 1678 |
|
|
2025
Q1 | $2.18M | Sell |
23,500
-55,200
| -70% | -$5.09M | ﹤0.01% | 4218 |
|
|
2024
Q4 | $7.15M | Buy |
+78,700
| New | +$7.23M | ﹤0.01% | 2229 |
|
|
2024
Q3 | – | Sell |
-20,000
| Closed | -$1.84M | – | 9517 |
|
|
2024
Q2 | $1.84M | Buy |
+20,000
| New | +$1.86M | ﹤0.01% | 4634 |
|
|
2023
Q1 | – | Sell |
-3,200
| Closed | -$267K | – | 8942 |
|
|
2022
Q4 | $267K | Sell |
3,200
-10,800
| -77% | -$974K | ﹤0.01% | 7217 |
|
|
2022
Q3 | $1.35M | Sell |
14,000
-4,600
| -25% | -$549K | ﹤0.01% | 4886 |
|
|
2022
Q2 | $1.96M | Buy |
18,600
+2,200
| +13% | +$281K | ﹤0.01% | 4204 |
|
|
2022
Q1 | $2.83M | Sell |
16,400
-4,500
| -22% | -$672K | ﹤0.01% | 4073 |
|
|
2021
Q4 | $3.38M | Sell |
20,900
-16,400
| -44% | -$2.64M | ﹤0.01% | 3490 |
|
|
2021
Q3 | $5.56M | Buy |
37,300
+21,400
| +135% | +$4.45M | ﹤0.01% | 2573 |
|
|
2021
Q2 | $3.89M | Buy |
15,900
+12,400
| +354% | +$3.25M | ﹤0.01% | 3076 |
|
|
2021
Q1 | $927K | Buy |
3,500
+2,600
| +289% | +$733K | ﹤0.01% | 5600 |
|
|
2020
Q4 | $264K | Sell |
900
-7,700
| -90% | -$1.97M | ﹤0.01% | 6585 |
|
|
2020
Q3 | $2.03M | Buy |
8,600
+7,300
| +562% | +$1.66M | ﹤0.01% | 3005 |
|
|
2020
Q2 | $258K | Sell |
1,300
-600
| -32% | -$112K | ﹤0.01% | 6048 |
|
|
2020
Q1 | $349K | Buy |
+1,900
| New | +$338K | ﹤0.01% | 4039 |
|
|
2019
Q2 | – | Sell |
-3,300
| Closed | -$407K | – | 5089 |
|
|
2019
Q1 | $407K | Buy |
+3,300
| New | +$414K | ﹤0.01% | 3904 |
|
Other funds holding AMED
IA
MCI
HNB
Jane Street's AMED Position: Q3 2025 in Review
Jane Street sold out of Amedisys (AMED) in Q3 2025, closing a stake of 48,371 shares — an estimated $4.76M sold.
Jane Street first reported a position in AMED in Q2 2014 and held it in 26 quarters. The position peaked at $15.5M in Q2 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Jane Street reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Jane Street sold 48,371 Amedisys shares in Q3 2025, an estimated $4.76M.
- Jane Street first reported a position in Amedisys in Q2 2014 and held it in 26 quarters.
- Jane Street's Amedisys position peaked at $15.5M in Q2 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.